• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

During intensive and long-lasting treatments, short-term or emergency care, children often undergo minor needle-related ...

In the context of a clinical trial, double-blind means that neither the patients nor the researchers know who is getting a placebo and who is getting the treatment. Because patients don't know what ...

Risk of bias assessment and quality of evidence Methodological quality ... Comparison with the control group (waitlist, usual care or placebo) Each of CBT (61 RCTs), computerised cognitive behavioural ...

In the other trials this event was reported to be similar in both the microbicide and placebo arms. Kreiss 1992 15 Unblinded RCT 138 female sex workers Nairobi, Kenya 1000 mg N-9 sponge/placebo ...

Trials at high or unclear risk of bias tend to overestimate benefits and underestimate harms.30 32–34 36–41 Despite biases inflating beneficial effects of review results, they still show only ...

We have all experienced how our expectations can influence our reactions, including our enjoyment or lack thereof of any event or interaction. Belief and confidence set the tide level for ...

The main foreseeable challenges of this study include the intention to recruit busy key stakeholders during the COVID-19 pandemic, recruitment bias and potential changes to policy or clinical services ...

New findings from CLEAR SYNERGY (OASIS 9) comparing spironolactone vs. placebo in patients with myocardial infarction (MI) found that the mineralocorticoid receptor antagonist did not reduce the ...

Placebo pills help you stay on course by taking one daily until the next month. Skipping them can reduce or stop periods. You can speak to your doctor for more advice. Birth control pills are ...